FDA Warning Letter — Barox Co., Ltd.
The FDA took a Warning Letter action against Barox Co., Ltd. on November 28, 2018 (Jungwon, Seongnam, South Korea). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Barox Co., Ltd.
- Date
- November 28, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Jungwon, Seongnam (South Korea)